compare glp-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Indications for GLP-1/GIP RA Summary
Description
Compounded semaglutide and tirzepatide products are not the same as FDA-approved brand-name medications
It is a telehealth platform that connects patients with licensed providers affiliated with independent medical groups
doi: 10.1073/pnas.2331316100
As these medications reduce overall energy intake, individuals are consuming fewer calories with estimates placing this reduction between 16 and 39%, or about 700 calories per day on average (Christensen et al., 2024)
Obesity has been demonstrated to raise the risk of high blood pressure in addition to CVD (43)
Dudum accused Novo of attempting to control how clinicians at Hims make decisions
